ROEL CONTRERAS: Open Payments
NPI 1336353390 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 15 payments from 5 companies in 2025. Trend: 2023 $208 · 2024 $360 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $102 |
| PFIZER INC. | 4 | $100 |
| Novo Nordisk Inc | 5 | $88 |
| Lilly USA, LLC | 2 | $59 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: FREESTYLE LIBRE 3, ELIQUIS, JARDIANCE, Wegovy, SHINGRIX, Rybelsus, Ozempic.
Industry payments across TX — which companies pay providers there.
